MENA Vaccine Market Outlook 2024, Share, Size, Key Players and Forecast By 2032

MENA Vaccine Market Overview

Base Year: 2023

Historical Years: 2018-2023

Forecast Years: 2024-2032

Market Growth Rate: 3.4% (2024-2032)

According to the latest report by IMARC Group, the MENA vaccine market size is projected to grow at a CAGR of 3.4% from 2024 to 2032. The market is growing due to rising healthcare investments, government immunization programs, and increasing demand for preventive healthcare.

MENA Vaccine Market Trends and Drivers:

The MENA vaccine market is expanding rapidly, owing to several interconnected factors. Primarily, the market is driven by the growing vaccination programs as well as public health campaigns. Besides this, regional government bodies are working harder to increase the number of people who have had vaccinations, particularly after the COVID-19 epidemic raised public awareness of the importance of preventative healthcare. Meanwhile, the MENA vaccine market is also influenced by international organizations like the WHO and UNICEF, which collaborate with MENA countries to promote immunization against diseases like polio, measles, and tuberculosis. Additionally, the rising investment in healthcare infrastructure and the introduction of advanced vaccine technologies are key factors bolstering the expansion of the market. In line with this, pharmaceutical companies in the region are enhancing production capabilities to meet the growing demand for vaccines.

A significant trend in the MENA vaccine market is the increasing focus on research and development of new vaccines for infectious and chronic diseases. With the ongoing threat of emerging diseases, countries are prioritizing vaccine innovation, leading to partnerships between global pharmaceutical giants and local manufacturers. Furthermore, the rising consciousness of the benefits of vaccination in preventing long-term healthcare costs is driving the adoption of vaccines across different age groups. In addition to this, the market is witnessing a shift towards sustainable vaccine production and distribution practices, emphasizing cost-effectiveness and accessibility. The expansion of private healthcare sectors and the establishment of vaccine production facilities in MENA countries are expected to drive the market. Consequently, the convergence of these factors is anticipated to propel the growth of the MENA vaccine market in the coming years.

Request for a sample copy of this report: https://www.imarcgroup.com/mena-vaccine-market/requestsample

MENA Vaccine Industry Segmentation:

The report has segmented the market into the following categories:

Product Type Insights:

• Multivalent Vaccine
• Monovalent Vaccine

Treatment Type Insights:

• Preventive Vaccine
• Therapeutic Vaccine

Technology Insights:

• Conjugate Vaccines
• Inactivated and Subunit Vaccines
• Live Attenuated Vaccines
• Recombinant Vaccines
• Toxoid Vaccines
• Others

Route of Administration Insights:

• Intramuscular and Subcutaneous Administration
• Oral Administration
• Others

Patient Type Insights:

• Pediatric
• Adult

Indication Insights:

• Bacterial Diseases

Meningococcal Disease

Pneumococcal Disease

Diphtheria/Tetanus/Pertussis (DPT)

Tuberculosis

Haemophilus Influenzae (Hib)

Typhoid

Others

• Viral Diseases

Hepatitis

Influenza

Human Papillomavirus (HPV)

Measles/Mumps/Rubella (MMR)

Rotavirus

Herpes Zoster

Varicella

Japanese Encephalitis

Rubella

Polio

Rabies

Dengue

Others

Distribution Channel Insights:

• Hospital Pharmacies
• Retail Pharmacies
• Institutional Sales
• Others

End User Insights:

• Hospitals
• Clinics
• Vaccination Centers
• Academic and Research Institutes
• Others

Country Insights:

• Saudi Arabia
• Turkey
• Israel
• United Arab Emirates
• Egypt
• Iran
• Iraq
• Qatar
• Algeria
• Kuwait
• Morocco
• Oman
• Others

Ask Analyst for Customization: https://www.imarcgroup.com/request?type=report&id=16112&flag=C

Competitive Landscape:

The report offers an in-depth examination of the competitive landscape. It includes a thorough competitive analysis encompassing market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant.

Key highlights of the Report:

• Market Performance (2018-2023)
• Market Outlook (2024-2032)
• COVID-19 Impact on the Market
• Porter’s Five Forces Analysis
• Strategic Recommendations
• Historical, Current and Future Market Trends
• Market Drivers and Success Factors
• SWOT Analysis
• Structure of the Market
• Value Chain Analysis
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145